世界经济论坛：2025年亚洲抗菌药物耐药性防控：精准施策与融资路径研究报告（英文版）

Investment in solutions to fight antimicrobial resistance in the Asia-Pacific could generate healthcare savings of $10-15 billion per year while cutting annual socio-economic costs by $35-40 billion. Antimicrobial resistance (AMR) is not just a looming health crisis – it is already a deadly reality, demanding urgent and coordinated global action. Globally, AMR was associated with approximately 4.71 million deaths in 2021, a figure projected to surge to 8.22 million by 2050, potentially surpas